Keith S Manchester Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 5 days, 12 hours ago
Keith S Manchester has an estimated net worth of at least $692.3 million*, as of June 3, 2026. They own 17.1 million shares of ROIV stock. They have sold 15.6 million shares of ROIV stock since 2021, for an estimated $202.2 million.
Keith S Manchester $ROIV SEC Form 4 Insider Trading
Keith S Manchester has filed a total of 24 insider trades in $ROIV since 2021. Their most recent trade was a sale of 425,000 shares, made on Feb 11, 2026. Their largest trade was a sale of 3.1 million shares, made on Sep 28, 2023. We estimate that they now own 17.1 million shares of $ROIV, worth an estimated $490.1 million.
Insider Trading at $ROIV
There have been a total of 258 insider trades reported at $ROIV since 2021, with 4.0 million shares purchased and 169.8 million shares sold. The most active insider traders in $ROIV stock have been Eric Venker, Rakhi Kumar, and Eric Venker. The most recent trade was a sale of 200,000 shares reported by Eric Venker (President & Immunovant CEO), made on May 22, 2026.
History of Insider Stock Trades by Keith S Manchester
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
ROIV
|
Sale | 425,000 | Feb 11, 2026 | Feb. 13, 2026, 10:02 p.m. |
|
ROIV
|
Sale | 225,000 | Feb 13, 2026 | Feb. 13, 2026, 10:02 p.m. |
|
ROIV
|
Sale | 150,784 | Feb 13, 2026 | Feb. 13, 2026, 10:02 p.m. |
|
ROIV
|
Sale | 275,000 | Feb 12, 2026 | Feb. 13, 2026, 10:02 p.m. |
|
ROIV
|
Sale | 150,000 | Feb 12, 2026 | Feb. 13, 2026, 10:02 p.m. |
|
ROIV
|
Sale | 642,282 | Dec 16, 2025 | Dec. 18, 2025, 8:52 p.m. |
|
ROIV
|
Sale | 275,000 | Dec 16, 2025 | Dec. 18, 2025, 8:52 p.m. |
|
ROIV
|
Sale | 432,718 | Dec 17, 2025 | Dec. 18, 2025, 8:52 p.m. |
|
ROIV
|
Sale | 155,076 | Dec 17, 2025 | Dec. 18, 2025, 8:52 p.m. |
|
ROIV
|
Sale | 189,538 | Dec 17, 2025 | Dec. 18, 2025, 8:52 p.m. |
|
ROIV
|
Sale | 850,000 | Nov 19, 2025 | Nov. 21, 2025, 9:24 p.m. |
|
ROIV
|
Sale | 175,000 | Nov 19, 2025 | Nov. 21, 2025, 9:24 p.m. |
|
ROIV
|
Sale | 125,000 | Nov 19, 2025 | Nov. 21, 2025, 9:24 p.m. |
|
ROIV
|
Sale | 150,000 | Nov 19, 2025 | Nov. 21, 2025, 9:24 p.m. |
|
ROIV
|
Sale | 368,052 | Sep 24, 2024 | Sept. 26, 2024, 8:35 p.m. |
|
ROIV
|
Sale | 134,948 | Sep 25, 2024 | Sept. 26, 2024, 8:35 p.m. |
ABUS
|
Sale | 8,846 | Aug 14, 2024 | Aug. 16, 2024, 4:07 p.m. |
|
ROIV
|
Sale | 1.1 million | Sep 28, 2023 | Oct. 2, 2023, 9:05 p.m. |
|
ROIV
|
Sale | 446,394 | Sep 28, 2023 | Oct. 2, 2023, 9:05 p.m. |
|
ROIV
|
Sale | 2.3 million | Sep 28, 2023 | Oct. 2, 2023, 9:05 p.m. |
|
ROIV
|
Sale | 3.1 million | Sep 28, 2023 | Oct. 2, 2023, 9:05 p.m. |
|
ROIV
|
Sale | 372,427 | Nov 10, 2022 | Nov. 14, 2022, 10:43 p.m. |
|
ROIV
|
Sale | 146,079 | Nov 10, 2022 | Nov. 14, 2022, 10:43 p.m. |
|
ROIV
|
Sale | 1.1 million | Nov 10, 2022 | Nov. 14, 2022, 10:43 p.m. |
|
ROIV
|
Sale | 2.3 million | Nov 10, 2022 | Nov. 14, 2022, 10:43 p.m. |
$ROIV Executives and Stock Owners with Insider Trades
-
Eric Venker, President & COO
-
Rakhi Kumar, Chief Accounting Officer
-
Eric Venker, President & Immunovant CEO
-
Matthew Gline, CEO
-
Eric Venker, Chief Operating Officer
-
Mayukh Sukhatme, Pres&Chief Investment Officer
-
Mayukh Sukhatme, President & CIO
-
Frank Torti, President and Vant Chair
-
Richard Pulik, CFO
-
Jennifer Humes, Chief Accounting Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.